缺血性中风和活跃癌症患者的生存预测因素:一个前性,多中心的观察性研究
Yasufumi Gon1, Manabu Sakaguchi1,2, Hiroshi Yamagami3
1Department of Neurology Osaka University Graduate School Medicine Osaka Japan.
Journal of the American Heart Association
|July 25, 2023
概括
癌症患者缺血性中风的预后因素受到中风原因,转移和凝血的影响. 升高的D-二次体水平表明结果较差,突出显示了凝血状况的重要性.
科学领域:
- 神经学 神经学
- 在瘤学瘤学.
- 血液学 血液学 血液学
背景情况:
- 关于患有缺血性中风并患有活跃癌症的患者的预后因素的数据有限.
- 了解这些因素对于改善患者的结果和指导治疗策略至关重要.
研究的目的:
- 调查影响急性缺血性中风和活跃癌症患者死亡率的预后因素.
- 在这个复杂的患者群体中确定生存的关键预测因素.
主要方法:
- 在日本进行了一项前性多中心观察性研究.
- 135名患有急性缺血性中风和活跃癌症的患者被跟踪了一年.
- 考克斯回归模型用于计算死亡风险比率,分析诸如中风原因,转移和凝血标记等因素.
主要成果:
- 与已知原因患者相比,患有密码性中风的患者的生存时间明显较短 (HR: 3.11 [95% CI,1.82-5.32]).
- 死亡率的独立预测因素包括远程转移,血D-二元水平升高和静脉血栓塞栓症并发症.
- 血D-二聚物水平有效地分层预后在患有缺血性中风和活跃癌症的患者.
结论:
- 患有急性缺血性中风和活跃癌症的患者的预后高度可变,受中风机制,转移和凝血状态的影响.
- 凝血异常,特别是通过D-二次元水平表明,是这些患者预后的关键决定因素.
相关概念视频
Cancer Survival Analysis
386
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
386
Assumptions of Survival Analysis
157
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
157
Comparing the Survival Analysis of Two or More Groups
225
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
225
Actuarial Approach
98
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
98
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


